Showing results (461-470 of 661) with videos related to
Sort By:
Pageof 67
European Journal of Cancer (Oxford, England : 1990)|May 31, 2022
Neoadjuvant chemotherapy improves survival in patients with oesophageal mucinous adenocarcinoma: Post-hoc analysis of the UK MRC OE02 and OE05 trialsDrolaiz H W Liu, Nina Šefčovičová, Jake Emmerson, et al.The Journal of Biological Chemistry|February 27, 2009
Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor designSeungil Han, Anil Mistry, Jeanne S Chang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2017
Pharmacogenetic Analysis of the UK MRC (Medical Research Council) MAGIC Trial: Association of Polymorphisms with Toxicity and Survival in Patients Treated with Perioperative Epirubicin, Cisplatin, and 5-fluorouracil (ECF) ChemotherapyElizabeth Smyth, Shenli Zhang, David Cunningham, et al.Blood|April 2, 2020
International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPIAmy S Ruppert, Jesse G Dixon, Gilles Salles, et al.Iscience|April 19, 2021
Teleguided self-ultrasound scanning for longitudinal monitoring of muscle mass during spaceflightJessica M Scott, Meghan Downs, David S Martin, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexedDavid C Farrugia, Hugo E R Ford, David Cunningham, et al.Journal of the National Cancer Institute|February 8, 2007
Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort studyAnthony J Swerdlow, Craig D Higgins, Paul Smith, et al.Cancer Immunology Research|March 20, 2026
Co-expression of IL15 promotes effector differentiation and sustained proliferative capacity in ALPPL2-specific human CAR T cellsDavid Cunningham, Junquan Liu, Inci Cevher Zeytin, et al.Cancers|October 20, 2020
Ramucirumab in Combination with Pembrolizumab in Treatment-Naïve Advanced Gastric or GEJ Adenocarcinoma: Safety and Antitumor Activity from the Phase 1a/b JVDF TrialIan Chau, Nicolas Penel, Andres O Soriano, et al.JCO Precision Oncology|September 11, 2020
Efficacy of Vemurafenib in Patients With Non-Small-Cell Lung Cancer With BRAF V600 Mutation: An Open-Label, Single-Arm Cohort of the Histology-Independent VE-BASKET StudyVivek Subbiah, Radj Gervais, Gregory Riely, et al.Pageof 67